Programme

09:00-09:30 h.

Inauguration

Dr. Ángel Carracedo. Director of Genomic medicine foundation
Dra. Angélica Figueroa. Principal Investigator of INIBIC

09:30-11:30 h.

Sesion I – innovation: drug discovery and development in cancer

CHAIR:

Dra. Mabel Loza. Professor of pharmacology at USC, scientific director and founder in Kaertor Foundation

→ 09:30-09:50 h.

Dra. Laura Soucek. Principal Investigator of VHIO´s Models of Cancer Therapies Group. ICREA Research Professor. Co-founder & CEO at PEPTOMYC S.L

THE JOURNEY OF A FIRST-IN-CLASS MYC INHIBITOR FROM BENCH TO CLINICAL TRIAL

 

→ 10:00-10:20 h.

Dr. Salvador A. Benitah. ICREA Senior Group Leader at IRB, Co-founder & CSO at ONA Therapeutics

EPIGENETIC CONSEQUENCES OF OUR (FATTY) DIET IN METASTASIS: ROLE OF SCHWANN CELLS

 

→ 10:30-10:50 h.

Dr. Héctor G. Palmer. Principal Investigator of VHIO´s Stem Cells and Cancer Group. Co-founder & CSO at Oniria Therapeutics

To be confirmed

 

→ 11:00-11:20 h.

Dra. Angélica Figueroa. Principal Investigator of INIBIC. Epithelial Plasticity and Metastasis Group

TARGETING PROTEIN DEGRADATION AGAINST CANCER

11:30-12:00 h.

BREAK AND POSTER SESSION

12:00-14:00 h.

Sesion II – CANCER RESEARCH WITH CLINICAL IMPACT

CHAIR:

Dr. Xose Bustelo. Full Professor at CSIC. Cancer Research Center-Salamanca University

→ 12:00-12:20 h.

Dr. Manuel Valiente. Principal investigator Brain Metastasis Group at CNIO

STRATEGIES TO CHALLENGE BRAIN METASTASIS LETHALITY IN MICE AND HUMAN

 

→ 12:30-12:50 h.

Dr. Javier de las Rivas. Principal Investigator at CSIC, Bioinformatics and Functional Genomics. Cancer Research Center Salamanca University

DISCOVERY OF GENE MARKERS ASSOCIATED WITH SURVIVAL AND RISK IN COLORECTAL CANCER (CRC) AND BREAST CANCER (BRCC)

 

→ 13:00-13:20 h.

Dr. Víctor Moreno. Director Clinical Research Phase 1 Trials Unit. START Madrid-FJD, Hospital Fundación Jiménez Díaz

CELLULAR THERAPY FOR SOLID TUMOURS

 

→ 13:30-14:00 h.

Dra. Sonia Zumalave. PhD candidate at Mobile Genomes Lab (CiMUS, University of Santiago de Compostela).

THE IMPACT OF SOMATIC RETROTRANSPOSON ACTIVITY IN THE ORIGIN AND DEVELOPMENT OF HUMAN CANCER

14:00-15:00 h.

BREAK

15:00-16:30 h.

Sesion IV – Young Researchers

CHAIR:

Dra. Esperanza Cerdán. Full Professor at Universidade da Coruña (UDC) / Advanced Scientific Research Center (CICA)

15:00-16:00 h.

Selected Short talks from received communications

16:30 h.

Award and closure

Dra. Angélica Figueroa. Principal Investigator of INIBIC
Dra. Esperanza Cerdán. Full Professor at Universidade da Coruña (UDC) / Advanced Scientific Research Center (CICA)